These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 23590130
1. Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing. Lee SR, Jung CK, Kim TE, Bae JS, Jung SL, Choi YJ, Kang CS. Thyroid; 2013 Nov; 23(11):1416-22. PubMed ID: 23590130 [Abstract] [Full Text] [Related]
2. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma. An JH, Song KH, Kim SK, Park KS, Yoo YB, Yang JH, Hwang TS, Kim DL. Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485 [Abstract] [Full Text] [Related]
3. BRAF and RAS mutations in follicular variants of papillary thyroid carcinoma. Park JY, Kim WY, Hwang TS, Lee SS, Kim H, Han HS, Lim SD, Kim WS, Yoo YB, Park KS. Endocr Pathol; 2013 Jun; 24(2):69-76. PubMed ID: 23625203 [Abstract] [Full Text] [Related]
4. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). Strickland KC, Eszlinger M, Paschke R, Angell TE, Alexander EK, Marqusee E, Nehs MA, Jo VY, Lowe A, Vivero M, Hollowell M, Qian X, Wieczorek T, French CA, Teot LA, Cibas ES, Lindeman NI, Krane JF, Barletta JA. Endocr Pathol; 2018 Mar; 29(1):68-74. PubMed ID: 29396809 [Abstract] [Full Text] [Related]
5. Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns. Rivera M, Ricarte-Filho J, Knauf J, Shaha A, Tuttle M, Fagin JA, Ghossein RA. Mod Pathol; 2010 Sep; 23(9):1191-200. PubMed ID: 20526288 [Abstract] [Full Text] [Related]
6. Preoperative RAS mutational analysis is of great value in predicting follicular variant of papillary thyroid carcinoma. Hwang TS, Kim WY, Han HS, Lim SD, Kim WS, Yoo YB, Park KS, Oh SY, Kim SK, Yang JH. Biomed Res Int; 2015 Sep; 2015():697068. PubMed ID: 25648502 [Abstract] [Full Text] [Related]
7. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma. Paek SH, Kim BS, Kang KH, Kim HS. World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392 [Abstract] [Full Text] [Related]
8. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma. Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ. Diagn Cytopathol; 2015 Oct 13; 43(10):786-90. PubMed ID: 26152656 [Abstract] [Full Text] [Related]
9. A morpho-molecular diagnosis of papillary thyroid carcinoma: BRAF V600E detection as an important tool in preoperative evaluation of fine-needle aspirates. Marchetti I, Lessi F, Mazzanti CM, Bertacca G, Elisei R, Coscio GD, Pinchera A, Bevilacqua G. Thyroid; 2009 Aug 13; 19(8):837-42. PubMed ID: 19534623 [Abstract] [Full Text] [Related]
10. Application of BRAF, NRAS, KRAS mutations as markers for the detection of papillary thyroid cancer from FNAB specimens by pyrosequencing analysis. Park SJ, Sun JY, Hong K, Kwak JY, Kim EK, Chung WY, Choi JR. Clin Chem Lab Med; 2013 Aug 13; 51(8):1673-80. PubMed ID: 23585181 [Abstract] [Full Text] [Related]
11. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status. Walts AE, Mirocha JM, Bose S. J Cancer Res Clin Oncol; 2015 Oct 13; 141(10):1749-56. PubMed ID: 25702102 [Abstract] [Full Text] [Related]
12. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Zou M, Baitei EY, Alzahrani AS, BinHumaid FS, Alkhafaji D, Al-Rijjal RA, Meyer BF, Shi Y. Thyroid; 2014 Aug 13; 24(8):1256-66. PubMed ID: 24798740 [Abstract] [Full Text] [Related]
13. Comprehensive Transcriptomic and Genomic Profiling of Subtypes of Follicular Variant of Papillary Thyroid Carcinoma. Song YS, Won JK, Yoo SK, Jung KC, Kim MJ, Kim SJ, Cho SW, Lee KE, Yi KH, Seo JS, Park YJ. Thyroid; 2018 Nov 13; 28(11):1468-1478. PubMed ID: 30226444 [Abstract] [Full Text] [Related]
14. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea. Kim M, Jeon MJ, Oh HS, Park S, Kim TY, Shong YK, Kim WB, Kim K, Kim WG, Song DE. Thyroid; 2018 Apr 13; 28(4):504-510. PubMed ID: 29439609 [Abstract] [Full Text] [Related]
15. The preeminence of growth pattern and invasiveness and the limited influence of BRAF and RAS mutations in the occurrence of papillary thyroid carcinoma lymph node metastases. Eloy C, Santos J, Soares P, Sobrinho-Simões M. Virchows Arch; 2011 Sep 13; 459(3):265-76. PubMed ID: 21796448 [Abstract] [Full Text] [Related]
16. Follicular variant of papillary thyroid carcinoma: accuracy of FNA diagnosis and implications for patient management. Ustun B, Chhieng D, Prasad ML, Holt E, Hammers L, Carling T, Udelsman R, Adeniran AJ. Endocr Pathol; 2014 Sep 13; 25(3):257-64. PubMed ID: 24696132 [Abstract] [Full Text] [Related]
17. Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities. Gupta S, Ajise O, Dultz L, Wang B, Nonaka D, Ogilvie J, Heller KS, Patel KN. Arch Otolaryngol Head Neck Surg; 2012 Mar 13; 138(3):227-33. PubMed ID: 22431868 [Abstract] [Full Text] [Related]
18. Follicular variant of papillary thyroid carcinoma: diagnostic limitations of fine needle aspiration cytology. Shih SR, Shun CT, Su DH, Hsiao YL, Chang TC. Acta Cytol; 2005 Mar 13; 49(4):383-6. PubMed ID: 16124166 [Abstract] [Full Text] [Related]
20. Cytomorphological Analysis of Thyroid Nodules Diagnosed as Follicular Variant of Papillary Thyroid Carcinoma: a Fine Needle Aspiration Study of Diagnostic Clues in 42 Cases and the Impact of Using Bethesda System in Reporting-an Institutional Experience. Trabzonlu L, Paksoy N. Endocr Pathol; 2018 Dec 13; 29(4):351-356. PubMed ID: 30315491 [Abstract] [Full Text] [Related] Page: [Next] [New Search]